Gardasil consists of 4 proteins of HPV Types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...
Gardasil 9 HPV Vaccine
Gardasil 9 consists of HPV proteins, Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, Polysorbate 80, sodium borate, and water for injection.Read more...
GBS6 Group B Streptococcus Vaccine
GBS6 is a multivalent group B streptococcus vaccine candidateRead more...
Gen-003 Genital Herpes (HSV2) Vaccine
GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...
GEN-009 Cancer Vaccine
GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...
GEO-CM01 SARS-CoV-2 Vaccine
GEO-CM01 vaccine candidate is based upon a novel platform that integrates our recombinant Modified Vaccinia Ankara (MVA) vector technology with advanced antigen design and state-of-the-art manufacturing technologies.Read more...
GEO-LM01 Lassa Fever Vaccine
GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...
GI.1/GII.4 Norovirus Vaccine
GI.1/GII.4 is a tablet oral norovirus vaccine consisting of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN. Read more...
GLS-5300 MERS-CoV Vaccine
GLS-5300 (INO-4700) is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.Read more...
GOVX-B11 HIV Vaccine
GOVX-B11 is a vaccine candidate that uses recombinant DNA and recombinant modified vaccinia Ankara (MVA) vaccines to express non-infectious virus-like particles. Read more...
